Table 2.
Physical observation of nonirradiated wounds after treatment with three biomaterials.
| Assessment (Score) | Mean ± SEM | ||
|---|---|---|---|
| Day 7 | Day 14 | Day 21 | |
| Infection-pus | |||
| Chitosan skin substitute | 1.0 ± 0 | 1.0 ± 0 | 1.0 ± 0 |
| Chitosan dermal substitute | 1.0 ± 0 | 1.0 ± 0 | 1.0 ± 0 |
| Duoderm CGF | 1.0 ± 0 | 1.0 ± 0 | 1.0 ± 0 |
| Hematoma | |||
| Chitosan skin substitute | 1.0 ± 0 | 1.3 ± 0.33 | 1.0 ± 0 |
| Chitosan dermal substitute | 1.0 ± 0 | 1.3 ± 0.33 | 1.0 ± 0 |
| Duoderm CGF | 1.0 ± 0 | 1.3 ± 0.33 | 1.0 ± 0 |
| Exudation | |||
| Chitosan skin substitute | 3.0 ± 0 | 3.0 ± 0 | 3.0 ± 0 |
| Chitosan dermal substitute | 3.0 ± 0 | 3.0 ± 0 | 3.0 ± 0 |
| Duoderm CGF | 3.0 ± 0 | 3.0 ± 0 | 3.0 ± 0 |
| Odor | |||
| Chitosan skin substitute | 3.0 ± 0 | 3.0 ± 0 | 3.0 ± 0 |
| Chitosan dermal substitute | 3.0 ± 0 | 3.0 ± 0 | 3.0 ± 0 |
| Duoderm CGF | 3.0 ± 0 | 3.0 ± 0 | 3.0 ± 0 |
| Flexibility | |||
| Chitosan skin substitute | 2.00 ± 0 | 2.7 ± 0.33 | 2.6 ± 0.24 |
| Chitosan dermal substitute | 1.8 ± 0.20 | 3.0 ± 0 | 2.6 ± 0.24 |
| Duoderm CGF | 2.4 ± 0.24 | 3.0 ± 0 | 2.4 ± 0.24 |
| Adherence | |||
| Chitosan skin substitute | 3.0 ± 0 | 2.0 ± 1.0 | 3.0 ± 0 |
| Chitosan dermal substitute | 3.0 ± 0 | 2.0 ± 1.0 | 3.0 ± 0 |
| Duoderm CGF | 2.4 ± 0.60 | 2.0 ± 1.0 | 3.0 ± 0 |
| Fluid accumulation | |||
| Chitosan skin substitute | 2.8 ± 0.20 | 2.0 ± 1.0 | 3.0 ± 0 |
| Chitosan dermal substitute | 3.0 ± 0 | 2.0 ± 1.0 | 3.0 ± 0 |
The means were not significantly different between biomaterials (P > 0.05).